closantel has been researched along with Retinal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, WX; Ma, Y; Peng, XY | 1 |
| Abrishami, M; Inanlou, B; Mansouri, MR; Masarat, H; Mirshahi, A; Pakrah, AR; Soleimani, M; Tabatabaei, SA | 1 |
| Boulton, JG; Cook, RW; Gill, PA; Kelly, WR; Reddacliff, LA; Vanselow, B | 1 |
3 other study(ies) available for closantel and Retinal Diseases
| Article | Year |
|---|---|
[Toxic retinopathy caused by veterinary antiparasitic closantel: a case report].
Topics: Adult; Antiparasitic Agents; Female; Fluorescein Angiography; Humans; Retina; Retinal Diseases; Retinal Pigment Epithelium; Salicylanilides; Tomography, Optical Coherence | 2023 |
Closantel; a veterinary drug with potential severe morbidity in humans.
Topics: Adult; Anthelmintics; Humans; Male; Retinal Diseases; Salicylanilides; Veterinary Drugs; Vision Disorders | 2016 |
Optic neuropathy and retinopathy in closantel toxicosis of sheep and goats.
Topics: Animals; Anthelmintics; Goat Diseases; Goats; Helminthiasis, Animal; Optic Nerve Diseases; Retinal Diseases; Salicylanilides; Sheep; Sheep Diseases | 1999 |